{"filing":{"accession_number":"0001628280-26-044806","cik":"0001818331","ticker":"WGSWW","company_name":"GeneDx Holdings Corp.","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"wgs-20260618.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1818331/000162828026044806/wgs-20260618.htm"},"events":[{"id":13033,"run_id":11564,"accession_number":"0001628280-26-044806","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the final voting results from GeneDx Holdings Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed tabulations of votes cast on four proposals: election of a Class II director (Katherine Stueland), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a standard shareholder vote results disclosure required under Item 5.07.","company_name":"GeneDx Holdings Corp.","ticker":"WGSWW","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10063,"accession_number":"0001628280-26-044806","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from GeneDx Holdings Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed tabulations of votes cast on four proposals: election of a Class II director (Katherine Stueland), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a standard shareholder vote results disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:36:49.265780+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10063,"accession_number":"0001628280-26-044806","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from GeneDx Holdings Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed tabulations of votes cast on four proposals: election of a Class II director (Katherine Stueland), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a standard shareholder vote results disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:36:49.265780+00:00","company_name":"GeneDx Holdings Corp.","ticker":"WGSWW","filing_date":"2026-06-23"}]}